Harvard Bioscience (HBIO) EPS (Basic) Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.25 Bn | 129.03 Bn | 1.96 Bn | 24.18% |
| 2 | Becton Dickinson | 52.47 Bn | 51.61 Bn | 2.32 Bn | 0.16% |
| 3 | Alcon | 35.69 Bn | 34.34 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.67 Bn | 32.20 Bn | 861.22 Mn | 18.97% |
| 5 | Medline | 29.17 Bn | 26.49 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.06 Bn | 24.62 Bn | 329.20 Mn | 1.12% |
| 7 | Solventum | 15.36 Bn | 14.95 Bn | 1.29 Bn | -33.83% |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | -58.57% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 33.97% |
| 10 | Harvard Bioscience | 33.61 Mn | 27.10 Mn | 12.63 Mn | -40.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -40.59% |
| Mar 31, 2026 | -94.09% |
| Dec 31, 2025 | -16.42% |
| Sep 30, 2025 | 30.35% |
| Jun 30, 2025 | -42.18% |
| Mar 31, 2025 | -89.41% |
| Dec 31, 2024 | -33.57% |
| Sep 30, 2024 | -197.51% |
| Jun 30, 2024 | -84.26% |
| Mar 31, 2024 | -85.97% |
| Dec 31, 2023 | 15.72% |
| Sep 30, 2023 | -0.44% |
| Jun 30, 2023 | 17.43% |
| Mar 31, 2023 | 28.51% |
| Dec 31, 2022 | -68.29% |
| Dec 31, 2021 | 62.88% |
| Jun 30, 2021 | -137.63% |
| Mar 31, 2021 | -32.65% |
| Dec 31, 2020 | -38.06% |
| Sep 30, 2020 | -85.45% |